Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study
Crossref DOI link: https://doi.org/10.1007/s00296-017-3682-9
Published Online: 2017-03-09
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Touma, Zahi
Sayani, Amyn
Pineau, Christian A.
Fortin, Isabelle
Matsos, Mark
Ecker, George A.
Chow, Andrew
Iczkovitz, Sandra
Funding for this research was provided by:
GSK
License valid from 2017-03-09